Global Bacterial Disease Diagnostics Market 2019-2023 | 6% CAGR Projection over the Next Five Years | Technavio

LONDON--()--The global bacterial disease diagnostics market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

A key factor driving the growth of the global bacterial disease diagnostics market size is the integration of digital health in rapid diagnostics for bacterial disease. The healthcare information technology (IT) segment has been very promising in the area of microbiology, as it has helped to understand various resistant bacterial strains. Digital health is increasingly being used in bacterial disease diagnostics to enhance accuracy levels, convenience, and affordability of various types of rapid diagnostics tests. The development of new diagnostics incorporated with digital technologies is helping healthcare professionals identify bacterial strains and provide better target appropriate treatment. Vendors are focusing on developing mobile applications that support portable rapid diagnostic systems to enable improved accuracy of tests. All these developments are expected to boost market growth over the forecast period.

As per Technavio, the high sensitivity and accuracy of chemiluminescence immunoassays will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global bacterial disease diagnostics market 2019-2023 research report also analyzes other significant trends and market drivers that will affect market growth over 2019-2023.

Global bacterial disease diagnostics market: High sensitivity and accuracy of chemiluminescence immunoassays

Enzyme immunoassay (EIA) that involves ELISA has been widely used across clinical laboratories, diagnostic centers, and hospitals for the diagnosis of various diseases. However, with diseases getting more complex, the need to detect smaller bacterial molecules has resulted in the emergence of the rapid automated analyzer, chemiluminescence immunoassay (CLIA). Chemiluminescence is proven to be a highly advantageous and cost-saving method for hospitals. Some of the advantages of CLIA over ELISA include increased sensitivity, reduced reagent consumption, improved precision, applicability to low abundance targets, reduced assay times, and increased throughput. Hence, the use of CLIA is rising, which is expected to positively impact the global bacterial disease diagnostics market growth during the forecast period.

“Apart from the high sensitivity and accuracy of chemiluminescence immunoassays, other factors such as the growing demand for portable analytical instruments, and increasing initiatives towards rapid diagnosis of infectious diseases will have a significant impact on the growth of the bacterial disease diagnostics market size during the forecast period,” says a senior analyst at Technavio.

Global bacterial disease diagnostics market: Segmentation analysis

This market research report segments the global bacterial disease diagnostics market by product (instruments, and consumables), and geographic regions (North America, Europe, Asia, and ROW).

The North American region led the bacterial disease diagnostics market in 2018, followed by Europe, Asia, and ROW, respectively. The growth of the bacterial disease diagnostics market in North America can be attributed to the increasing prevalence of bacterial diseases such as TB, meningitis, pneumonia, and the development of new antibacterial drugs. Also, increased funding for the development of new therapies for the treatment of infectious diseases has contributed to the market dominance of this region.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

The global bacterial disease diagnostics market is expected to post a CAGR of close to 6% during the period 2019-2023, according to Technavio.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com